Company: CMND
Filing Date: 2025-09-19
Form Type: F-1
Source: 0001213900-25-089545
Chunk: 18

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-19
Form: F-1
Chunk 18
---

on other fronts with various extremist groups in the region, such as various rebel militia groups in Syria and Iraq. In October 2024,
Israel began limited ground operations against Hezbollah in Lebanon, and in November 2024, a ceasefire was brokered between Israel and
Hezbollah. It is possible that hostilities with Iran, Hezbollah, the Houthis and Syria will escalate, and that other terrorist organizations,
including Palestinian military organizations in the West Bank, will join the hostilities. In addition, Iran launched direct attacks on
Israel in April 2024 and October 2024 involving hundreds of drones and missiles, has threatened to continue to attack Israel, and is widely
believed to be developing nuclear weapons. In addition, in June 2025, in light of continued nuclear threats and intelligence assessments
indicating imminent attacks, Israel launched a preemptive strike directly targeting military and nuclear infrastructure inside Iran, aimed
at disrupting Iran’s capacity to coordinate or launch further hostilities against Israel, as well as to degrade its nuclear program.
In response, Iran launched multiple waves of drones and ballistic missiles at Israeli cities, including Tel Aviv, Haifa, and Jerusalem.
While most of these attacks were intercepted, several caused civilian casualties and damage to infrastructure. The Israeli military conducted
additional operations against Iranian assets. While a ceasefire was reached between Israel and Iran in June 2025 after 12 days of hostilities,
the situation remains volatile. A broader regional conflict involving additional state and non-state actors remains a significant risk.
Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the
Houthis in Yemen and various rebel militia groups in Syria and Iraq. These situations may potentially escalate in the future to more violent
events which may affect Israel and us. Any hostilities, armed conflicts, terrorist activities involving Israel or the interruption or
curtailment of trade between Israel and its trading partners, or any political instability in the region could adversely affect business
conditions and our results of operations and could make it more difficult for us to raise capital and could adversely affect the market
price of our ordinary shares. An escalation of tensions or violence might result in a significant downturn in the economic or financial
condition of Israel, which could have a material adverse effect on our operations in Israel and our business. Parties with whom we do
business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements
when necessary in order to